Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7694221 | 0.78 | THRB (0.32) | THRBLMNA | |
| SCHEMBL9494334 | 0.71 | — | — | |
| SCHEMBL11486807 | 0.71 | THRB (0.44) | THRBLMNA | |
| SCHEMBL5075134 | 0.71 | — | — | |
| SCHEMBL31296259 | 0.71 | THRB (0.44) | THRBLMNA | |
| SCHEMBL339818 | 0.69 | — | — | |
| SCHEMBL29732253 | 0.69 | — | — | |
| SCHEMBL1772944 | 0.67 | — | — | |
| SCHEMBL8109397 | 0.67 | — | — | |
| SCHEMBL11661782 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113896639-A | 3-methoxy methyl acrylate preparation system | 昂吉(上海)环保新材料科技有限公司 | 2022-01-07 | — | — | CN | disclosed |
| CN-113896634-A | Preparation method of 3-methoxy methyl acrylate | 昂吉(上海)环保新材料科技有限公司 | 2022-01-07 | — | — | CN | disclosed |
| CN-109746042-B | Catalyst for synthesizing 3-methoxy methyl acrylate and solid-supported and using method | 衢州学院 | 2021-08-27 | — | — | CN | disclosed |
| EP-1200414-B1 | PROCESS FOR THE PREPARATION OF SUBSTITUTED PYRIMIDINES | BASF AG (DE) | 2005-04-20 | — | — | EP | disclosed |
| WO-2003076409-A1 | DERIVATIVES OF 1-PHENYL-3-PHENYLPYRAZOLE AS HERBICIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2003-09-18 | — | — | WO | disclosed |
| US-6559307-B2 | Cyclization of an amidine compound with a vinylcarbonyl compound | BASF AKTIENGESELLSCHAFT (DE) | 2003-05-06 | — | — | US | disclosed |
| US-20020004600-A1 | Process for the preparation of substituted pyrimidines | AMERICAN CYANAMID COMPANY | 2002-01-10 | — | — | US | disclosed |
| US-6281358-B1 | REACTING AN AMIDINE COMPOUND WITH A VINYLCARBONYL COMPOUNDIN INERT SOLVENT IN PRESENCE OF BASE | AMERICAN CYANAMID COMPANY | 2001-08-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020004600-A1 | Process for the preparation of substituted pyrimidines | XRN2, HPRT1, POLR2H | THRB 2561/4885LMNA 926/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.